Fortrea Holdings Inc.

# Fortrea Holdings Inc. (FTRE)

Fortrea is a contract research organization providing clinical development and consulting services to pharmaceutical, biotechnology, and medical device companies. The company operates across the full spectrum of clinical trials, offering phase I through IV clinical trial management, clinical pharmacology services, and specialized consulting. Fortrea delivers these services through multiple engagement models, including full-service arrangements, functional service provider structures, and hybrid delivery approaches tailored to client needs.

The company maintains strategic collaborations to enhance its service offerings. A partnership with Emery Pharma provides specialized testing for rifampin impurities in drug-drug interaction studies, ensuring compliance with FDA guidelines. A second collaboration with SCT Cell Manufacturing supports the development and acceleration of advanced therapeutic solutions.

Based in Durham, North Carolina, Fortrea operates globally and serves a worldwide customer base across the biopharmaceutical and medical device sectors. The organization has approximately 14,500 full-time employees and operates with a market capitalization of $1.0 billion. The company was incorporated in 2023.